HDAC3 has been detected to be a new potential target for atherosclerosis therapy, as deletion of HDAC3 can promote M2 activation while inhibiting M1 polarization.123 These two characteristics are considered to be the advantages of atherosclerosis therapy. This evidence concerns the gene HDAC3 and atherosclerosis.